Getting the Facts: Drug Companies Increasingly Using Patent Games to Avoid Competition
A recent article published by STAT highlights how Big Pharma is using continuation patents to keep lower-cost generic drugs from reaching the market.
The health care landscape is changing, and here’s where you can keep up. AHIP is your source for the latest health policy news and information, fact sheets, press releases, expert interviews, in-depth reports, and more.
A recent article published by STAT highlights how Big Pharma is using continuation patents to keep lower-cost generic drugs from reaching the market.
A study published in Health Affairs found that new brand-name pharmaceutical competition resulted in decreases in net prices of existing drugs.
Drug makers have increased prices on 847 brands so far in 2023.
As Pharma hides the high prices of prescriptions, health insurance providers negotiate lower costs, more affordable choices for Americans